共 9 条
[1]
Adrenergic receptor polymorphisms and cardiac function(and dysfunction): a failure to communicate. Feldman RD. Circulation . 2001
[2]
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure Analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). Wikstrand J,Hjalmarson A,Waagstein F,et al. Journal of the American College of Cardiology . 2002
[3]
Effects of carvedilol on survival in severe chronic heart failure. Packer M,Coats AJ,Fowler MB,et al. The New England Journal of Medicine . 2001
[4]
A randomised trial of the angiotensin-receptor blocker valsartan in chronic heart failure. Cohn JN,Tognoni G. The New England Journal of Medicine . 2001
[5]
Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure. Swedberg K,Bristow MR,Cohn JN,et al. Circulation . 2002
[6]
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. Beta-Blocker Evaluation of Survival Trial Investigators. The New England Journal of Medicine . 2001
[7]
Lesser response to angiotensinconverting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. Exner DV,Dries DL,Domanski MJ. The New England Journal of Medicine . 2001
[8]
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Trial in Congestive Heart Failure(MERIT-HF). MERIT-HF Study Group. The Lancet . 1999
[9]
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult:executive summary.A report of the ACC/AHA task force on practice guidelines. Hunt SA,Baker DW,Chin MH,et al. Journal of the American College of Cardiology . 2001